Virax Biolabs Shares Surge After Signing Exclusive Distribution Deal with Fosun Diagnostics
Shares of Virax Biolabs (NASDAQ:VRAX) doubled after announcing an exclusive commercial supply agreement with Fosun Diagnostics for its ImmuneSelect immune profiling products in six Southeast Asian countries. The deal supports near-term revenue growth and regional expansion, focusing initially on tuberculosis research applications.
Topics: Biotech Expansion Partnership Pharmaceuticals